Risk Factors and Outcomes for COVID-19 in Autoimmune Inflammatory Diseases during the SARS-CoV-2 Pandemic: A

Olga Vera-Lastra1,2,3, Erik Cimé-Aké1,2, Alberto Ordinola Navarro1,2

  • 1Department of Internal Medicine and Pathological Anatomy, Antonio Fraga Mouret National Medical Center, La Raza, México City, Mexico.

Insights

Patients with autoimmune disease (AID) experienced better outcomes during COVID-19 infection compared to controls. Anticoagulant therapy was linked to reduced mortality in AID patients with COVID-19.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Rheumatology

Background:

  • Patients with autoimmune diseases (AID) face increased mortality risk from COVID-19 due to comorbidities and immunosuppressive therapies.
  • Understanding the specific risks and outcomes for AID patients with COVID-19 is crucial for clinical management.

Purpose of the Study:

  • To investigate and compare the risk factors and clinical outcomes of COVID-19 patients with and without autoimmune diseases (AID).
  • To identify predictors of severe disease and mortality in the context of COVID-19 and AID.

Main Methods:

  • A prospective cohort study design was employed, comparing 113 COVID-19 patients with AID to 113 matched controls.
  • Data collected included clinical characteristics, biochemical markers, immunological treatments, and outcomes such as hospitalization duration, invasive mechanical ventilation (IMV), and mortality.

Main Results:

  • Autoimmune disease patients exhibited lower levels of lactate dehydrogenase, C-reactive protein, and fibrinogen, along with reduced rates of IMV and lower in-hospital mortality compared to controls.
  • Low oxygen saturation (SaO2 ≤ 88%) at hospitalization was a significant risk factor for IMV and in-hospital mortality.
  • Anticoagulant therapy demonstrated a protective effect, associated with lower death rates in the AID group.

Conclusions:

  • Patients with autoimmune diseases (AID) demonstrated more favorable outcomes when infected with COVID-19 compared to non-AID controls.
  • Anticoagulation emerged as a key factor associated with reduced mortality among AID patients diagnosed with COVID-19.
Abstract

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
697
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.3K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
85
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
81
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.5K